Toronto Ottawa Heart Summit - Heart Failure Update

Abstracts

Abstract Submission Guidelines

IMPORTANT DATES

  • Call for Abstract Opens: August 13, 2021
  • Deadline for Submission: September 7, 2021
  • Notification to Applicants: September 16, 2021

The Toronto-Ottawa Heart Summit will take place virtually on September 24-25, 2021.

The 23rd Toronto-Ottawa Heart Summit: Resolving Ongoing Controversies in CV Disease promises to bring together national and international experts and stakeholders to provide the latest discoveries and innovations in cardiovascular health and professional interactions that help to define the current frontiers in cardiovascular science.

The program is an accredited opportunity for knowledge exchange for a variety of stakeholders including scientists, clinician investigators, primary care physicians, allied health professionals, trainees. The 2-day virtual event will feature plenary sessions, panel discussions, poster displays and networking opportunities.

The Scientific Review Committee for this year's program is now seeking abstracts of original research in Cardiovascular Disease for Poster and Rapid-Fire Oral Presentations. Please read this guideline carefully before completing the online submission form, which can be found here.

ABSTRACT SUBMISSION DEADLINE: September 7, 2021

Eligibility Requirements for Submission of Abstracts:

  • Fellows enrolled in a clinical training program
  • Residents enrolled in a clinical training program
  • Medical students
  • Postdoctoral fellows
  • Graduate students
  • Undergraduate students

HOW TO SUBMIT:

Participants may submit either of the following types of abstracts:

Basic Science:
Identify major advances in key areas of cutting-edge research and technology in heart failure, atherosclerosis, stroke, cardiovascular genetics, molecular biology and arrhythmias.

Understand basic processes linking molecular and cellular biology and biochemistry with cardiovascular physiology and pathophysiology.

Clinical Science:
Translate emerging clinical science to clinical practice in patients with cardiovascular disease.

  • Coronary Artery Disease, Acute Coronary Syndromes, Acute Cardiac Care
  • Atrial Fibrillation, Arrhythmias
  • Preventive Cardiology
  • Population Health & Behavioural Science
  • Heart Failure
  • Personalized Medicine
  • Policy & Guidelines

Note: If you do not know which category your abstract falls within, select 'Undeclared' on the abstract submission form and the Scientific Review Committee will assign a category.

Please follow the guidelines for abstract submission as outlined below:

Abstract Revisions:
After the September 7, 2021 deadline, abstracts may not be revised in any way or resubmitted. Proofread abstracts carefully to avoid errors before submission. If accepted, your abstract will be published as submitted.

Abstract Withdrawal:
Abstracts may be withdrawn by emailing the Conference Coordinator at Toronto-Ottawa-Heart-Summit@ottawaheart.ca.

Abstract Acceptance:
Abstracts are selected on the basis of scientific merit and are assigned as either oral or poster presentations. Notification of acceptance of abstract will be emailed no later than September 16, 2021.

EVALUATION CRITERIA
Using a blind review process, the Scientific Review Committee will review the abstracts using the following criteria:

Abstract Scoring Criteria:

  • Originality
  • Design and Methodology
  • Supporting Data
  • Impact

Click on the BUTTON for more information:

Opt-in/Opt-out of Email Lists

In compliance with anti-spam initiatives: